Q4 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DYN | Sell | Dyne Therapeutics, Inc. | $27,594,667 | +38.7% | 2,074,787 | -6.5% | 32.85% | +6.7% |
| PRAX | Exit | Praxis Precision Medicines, Inc. | $0 | – | -1,469,665 | – | -3.89% | – |
Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IKNA | New | Ikena Oncology, Inc. | $975,081 | – | 225,192 | – | 1.51% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DYN | New | Dyne Therapeutics, Inc. | $24,975,383 | – | 2,220,034 | – | 32.61% | – |
| CNTA | New | Centessa Pharmaceuticals plcordinary shares | $24,337,953 | – | 3,931,818 | – | 31.78% | – |
| ALLO | New | Allogene Therapeutics, Inc. | $8,936,870 | – | 1,798,163 | – | 11.67% | – |
| KNTE | New | Kinnate Biopharma, Inc. | $6,689,549 | – | 2,207,772 | – | 8.73% | – |
| New | LianBioordinary shares | $5,203,152 | – | 2,282,084 | – | 6.79% | – | |
| KRON | New | Kronos Bio, Inc. | $4,756,340 | – | 2,765,314 | – | 6.21% | – |
| PRAX | New | Praxis Precision Medicines, Inc. | $1,690,115 | – | 1,469,665 | – | 2.21% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FIXX | Exit | Homology Medicines, Inc. | $0 | – | -696,289 | – | -1.01% | – |
| Exit | LianBioordinary shares | $0 | – | -2,282,084 | – | -4.10% | – | |
| PRAX | Exit | Praxis Precision Medicines, Inc. | $0 | – | -2,939,329 | – | -5.99% | – |
| KRON | Exit | Kronos Bio, Inc. | $0 | – | -2,765,314 | – | -8.31% | – |
| CNTA | Exit | Centessa Pharmaceuticals plcordinary shares | $0 | – | -3,931,818 | – | -14.18% | – |
| ALLO | Exit | Allogene Therapeutics, Inc. | $0 | – | -1,798,163 | – | -17.43% | – |
| KNTE | Exit | Kinnate Biopharma, Inc. | $0 | – | -2,207,772 | – | -23.68% | – |
| DYN | Exit | Dyne Therapeutics, Inc. | $0 | – | -2,220,034 | – | -25.30% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DYN | Sell | Dyne Therapeutics, Inc. | $28,194,000 | +38.6% | 2,220,034 | -25.0% | 25.30% | +47.3% |
| KNTE | Sell | Kinnate Biopharma, Inc. | $26,383,000 | -23.8% | 2,207,772 | -19.6% | 23.68% | -19.1% |
| FIXX | Sell | Homology Medicines, Inc. | $1,121,000 | -26.2% | 696,289 | -9.7% | 1.01% | -21.7% |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | New | Kinnate Biopharma, Inc. | $34,645,000 | – | 2,747,433 | – | 29.28% | – |
| ALLO | New | Allogene Therapeutics, Inc. | $20,499,000 | – | 1,798,163 | – | 17.32% | – |
| DYN | New | Dyne Therapeutics, Inc. | $20,335,000 | – | 2,960,046 | – | 17.18% | – |
| CNTA | New | Centessa Pharmaceuticals plcordinary shares | $19,148,000 | – | 3,931,818 | – | 16.18% | – |
| KRON | New | Kronos Bio, Inc. | $10,066,000 | – | 2,765,314 | – | 8.51% | – |
| PRAX | New | Praxis Precision Medicines, Inc. | $7,201,000 | – | 2,939,329 | – | 6.08% | – |
| New | LianBioordinary shares | $4,929,000 | – | 2,282,084 | – | 4.16% | – | |
| FIXX | New | Homology Medicines, Inc. | $1,519,000 | – | 770,845 | – | 1.28% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FIXX | Exit | Homology Medicines, Inc. | $0 | – | -770,845 | – | -1.74% | – |
| OYST | Exit | Oyster Point Pharma, Inc. | $0 | – | -640,070 | – | -2.17% | – |
| ALLO | Exit | Allogene Therapeutics, Inc. | $0 | – | -1,798,163 | – | -13.24% | – |
| DYN | Exit | Dyne Therapeutics, Inc. | $0 | – | -2,960,046 | – | -13.77% | – |
| PRAX | Exit | Praxis Precision Medicines, Inc. | $0 | – | -2,939,329 | – | -15.57% | – |
| KRON | Exit | Kronos Bio, Inc. | $0 | – | -2,765,314 | – | -16.60% | – |
| KNTE | Exit | Kinnate Biopharma, Inc. | $0 | – | -2,747,433 | – | -18.11% | – |
| CNTA | Exit | Centessa Pharmaceuticals plcordinary shares | $0 | – | -3,931,818 | – | -18.81% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OYST | Sell | Oyster Point Pharma, Inc. | $7,585,000 | -33.0% | 640,070 | -2.8% | 2.17% | -23.5% |
| ASMB | Exit | Assembly Biosciences, Inc. | $0 | – | -384,635 | – | -0.37% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | New | Centessa Pharmaceuticals plcordinary shares | $87,326,000 | – | 3,931,818 | – | 21.90% | – |
| KRON | New | Kronos Bio, Inc. | $66,229,000 | – | 2,765,314 | – | 16.61% | – |
| KNTE | New | Kinnate Biopharma, Inc. | $63,960,000 | – | 2,747,433 | – | 16.04% | – |
| DYN | New | Dyne Therapeutics, Inc. | $62,280,000 | – | 2,960,046 | – | 15.62% | – |
| PRAX | New | Praxis Precision Medicines, Inc. | $53,731,000 | – | 2,939,329 | – | 13.47% | – |
| ALLO | New | Allogene Therapeutics, Inc. | $46,896,000 | – | 1,798,163 | – | 11.76% | – |
| OYST | New | Oyster Point Pharma, Inc. | $11,319,000 | – | 658,468 | – | 2.84% | – |
| FIXX | New | Homology Medicines, Inc. | $5,604,000 | – | 770,845 | – | 1.40% | – |
| ASMB | New | Assembly Biosciences, Inc. | $1,492,000 | – | 384,635 | – | 0.37% | – |
Q4 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASMB | Exit | Assembly Biosciences, Inc. | $0 | – | -450,000 | – | -4.63% | – |
| FIXX | Exit | Homology Medicines, Inc. | $0 | – | -770,845 | – | -5.17% | – |
| OYST | Exit | Oyster Pt Pharma Inc | $0 | – | -778,468 | – | -10.29% | – |
| DYN | Exit | Dyne Therapeutics, Inc. | $0 | – | -2,960,046 | – | -37.43% | – |
| ALLO | Exit | Allogene Therapeutics, Inc. | $0 | – | -1,798,163 | – | -42.47% | – |
Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALLO | New | Allogene Therapeutics, Inc. | $67,809,000 | – | 1,798,163 | – | 42.47% | – |
| DYN | New | Dyne Therapeutics, Inc. | $59,764,000 | – | 2,960,046 | – | 37.43% | – |
| OYST | New | Oyster Pt Pharma Inc | $16,433,000 | – | 778,468 | – | 10.29% | – |
| FIXX | New | Homology Medicines, Inc. | $8,248,000 | – | 770,845 | – | 5.17% | – |
| ASMB | New | Assembly Biosciences, Inc. | $7,398,000 | – | 450,000 | – | 4.63% | – |